EKF Diagnostics Holdings PLC Holding(s) in Company (5824Z)
May 27 2016 - 10:17AM
UK Regulatory
TIDMEKF
RNS Number : 5824Z
EKF Diagnostics Holdings PLC
27 May 2016
The following amendment(s) has (have) been made to the
'Holding(s) in Company' announcement released on 25 May 2016 at
12.47 under RNS No 2919Z.
Additional information has been added to section 13 in relation
to Christopher Mills, Non-Executive Chairman of EKF, who has an
indirect beneficial interest in the shareholding that is subject to
the below TR-1.
All other details remain unchanged.
The full amended text is shown below.
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or EKF Diagnostics Holdings
the underlying issuer Plc
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- --------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights YES
-------------------------------------------------------------- -----------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------- -----------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------- -----------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------- -----------------------------------
Other (please
specify):
------------------------------------------------------- ----- -----------------------------------
3. Full name of person(s) Harwood Capital LLP (as investment
subject to the adviser/manager) and North
notification obligation: Atlantic Smaller Companies
(iii) Investment Trust plc
--------------------------------------------------------- ----------------------------------------
4. Full name of shareholder(s) 1. North Atlantic Smaller
(if different from 3.):(iv) Companies Investment Trust
PLC
2. Oryx International Growth
Fund Limited
--------------------------------------------------------- ----------------------------------------
5. Date of the transaction 20 MAY 2016
and date on
which the threshold is
crossed or
reached: (v)
--------------------------------------------------------- ----------------------------------------
6. Date on which issuer 24 MAY 2016
notified:
--------------------------------------------------------- ----------------------------------------
7. Threshold(s) that is/are ABOVE 19%
crossed or
reached: (vi, vii)
--------------------------------------------------------- ----------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- ---------------------------------- -----------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
------------- ---------------- ---------------- -------------- ---------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ------------ ------------ -------------- -------------- ------------ ------------ -----------
46,300,000
GB0031509804 35,350,000
---------------- ------------ -----------
Holder 1: 46,300,000 48,650,000 48,650,000 11.53%
Holder 2: 35,350,000 35,350,000 35,350,000 8.38%
------------- ------------ ---------------- -------------- -------------- ------------ ------------ ---------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
----------------- -------------- -------------------------------- ------------------------------ ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- -------------- -------------- ---------------- ------------------------------ -----------------------
Nominal Delta
--------------- -------------- -------------- ---------------- ------------------------------ ------------ ---------
Total (A+B+C)
--------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------- ---------------------------------------------------------------------
84,00,000 19.90%
--------------------------------------------------- ---------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- -----------------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- -----------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- -----------------------------------
Christopher Mills, Non-Executive
13. Additional information: Chairman of EKF, has an indirect
beneficial interest in the
above shares. He is a director
of Oryx International Growth
Fund Limited and North American
Smaller Companies Investment
Trust plc. He holds 2.16
percent. of the shares in
Oryx International Growth
Fund Limited in his own name
and 46.44 per cent. via his
25.06 per cent. shareholding
in North American Smaller
Companies Investment Trust
plc. The price paid for the
shares is 11pence.
Harwood Capital LLP is investment
manager to North Atlantic
Smaller Companies Investment
Trust plc and investment
adviser to Oryx International
Growth Fund Limited. Harwood
Capital LLP is a limited
liability partnership of
which Christopher Mills is
a partner and Chief Investment
Officer.
------------------------------------------------------------- -----------------------------------
14. Contact name: Jane Muir
------------------------------------------------------------- -----------------------------------
15. Contact telephone number: 0200 8819 6486
------------------------------------------------------------- -----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUBASRNUAVUAR
(END) Dow Jones Newswires
May 27, 2016 10:17 ET (14:17 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Sep 2023 to Sep 2024